Carregant...
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy
This 2-part, double-blind, placebo-controlled study was conducted to determine the safety and efficacy of etoricoxib, a COX-2 selective inhibitor, for the treatment of hemophilic arthropathy. In part 1 (6 weeks), 102 patients (≥ 12 years old) with hemophilic arthropathy were randomized to receive 90...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
© 2006 by The American Society of Hematology
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1895698/ https://ncbi.nlm.nih.gov/pubmed/16291600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2004-09-3501 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|